QCRH_logoTag_cmyk.jpg
QCR Holdings, Inc. to Report Second Quarter 2024 Financial Results
July 03, 2024 16:05 ET | QCR Holdings, Inc.
MOLINE, Ill., July 03, 2024 (GLOBE NEWSWIRE) -- QCR Holdings, Inc. (NASDAQ: QCRH) (“QCRH” or the “Company”) announced today that its second quarter ended June 30, 2024 financial results will be...
BRKL-Bancorp-Logo-RGB-Color.jpg
Brookline Bancorp, Inc. Announces Second Quarter 2024 Earnings Release Date and Conference Call
July 03, 2024 16:05 ET | Brookline Bancorp, Inc.
BOSTON, July 03, 2024 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ: BRKL) announced today that it will report second quarter 2024 earnings at the close of business on Wednesday, July 24,...
Logo.png
Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination
July 03, 2024 16:05 ET | Kernel Group Holdings, Inc
New York, July 03, 2024 (GLOBE NEWSWIRE) -- Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) (“KRNL” or the “Company”), a special purpose acquisition company, announced today that it has...
churchill downs logo.jpg
Churchill Downs Incorporated Closes Amendment to Extend Maturity Date of its Revolving Credit Facility and Term Loan A Facility
July 03, 2024 16:01 ET | Churchill Downs Incorporated
LOUISVILLE, Ky., July 03, 2024 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) (Nasdaq: CHDN) announced today that CDI successfully closed an amendment of its senior...
NewAmsterdam Logo_full color_Final.png
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2024 16:01 ET | NewAmsterdam Pharma N.V.
NAARDEN, The Netherlands and MIAMI, July 03, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
Arcutis logo.png
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2024 16:00 ET | Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in...
Picture1.jpg
ToughBuilt Industries, Inc. Announces Receipt of Nasdaq Staff Determination Letter and Hearing Request
July 03, 2024 16:00 ET | ToughBuilt Industries, Inc.
IRVINE, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- ToughBuilt Industries, Inc. (Nasdaq: TBLT) ("ToughBuilt" or the "Company"), today announced its receipt of a Staff Determination letter from the...
Cytokinetics.png
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
July 03, 2024 16:00 ET | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on June 28, 2024 it granted stock options to purchase an aggregate of...
Absci-NameLogo.png
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2024 16:00 ET | Absci Corporation
VANCOUVER, Wash. and NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on July 1, 2024, the company...
Plains_Full_Color.jpg
Plains All American Pipeline and Plains GP Holdings Announce Quarterly Distributions and Timing of Second-Quarter 2024 Earnings HOUSTON, July 03, 2024 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today announced their quarterly distributions with respect to the...